208 related articles for article (PubMed ID: 31470782)
1. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta N; Frias MA; Vuilleumier N; Pagano S
Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
[TBL] [Abstract][Full Text] [Related]
2. The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity.
Fernandes das Neves M; Batuca JR; Delgado Alves J
Immunology; 2021 Oct; 164(2):231-241. PubMed ID: 33934336
[TBL] [Abstract][Full Text] [Related]
3. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
[TBL] [Abstract][Full Text] [Related]
5. Humoral mechanisms of atherogenesis.
Batuca JR; Amaral MC; Alves JD
Ann N Y Acad Sci; 2009 Sep; 1173():401-8. PubMed ID: 19758179
[TBL] [Abstract][Full Text] [Related]
6. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.
Satta N; Vuilleumier N
Curr Drug Targets; 2015; 16(4):342-60. PubMed ID: 25429713
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
8. ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies.
Lorenzo C; Delgado P; Busse CE; Sanz-Bravo A; Martos-Folgado I; Bonzon-Kulichenko E; Ferrarini A; Gonzalez-Valdes IB; Mur SM; Roldán-Montero R; Martinez-Lopez D; Martin-Ventura JL; Vázquez J; Wardemann H; Ramiro AR
Nature; 2021 Jan; 589(7841):287-292. PubMed ID: 33268892
[TBL] [Abstract][Full Text] [Related]
9. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.
Chistiakov DA; Orekhov AN; Bobryshev YV
Lab Invest; 2016 Jul; 96(7):708-18. PubMed ID: 27183204
[TBL] [Abstract][Full Text] [Related]
10. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
[TBL] [Abstract][Full Text] [Related]
11. [The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].
Babintseva YD; Camont L; Chapman J; Lhomme M; Karagodin VP; Kontush A; Orekhov AN
Ter Arkh; 2016; 88(9):111-118. PubMed ID: 28635814
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease biomarkers across autoimmune diseases.
Ahearn J; Shields KJ; Liu CC; Manzi S
Clin Immunol; 2015 Nov; 161(1):59-63. PubMed ID: 26168705
[TBL] [Abstract][Full Text] [Related]
13. Is preclinical autoimmunity benign?: The case of cardiovascular disease.
Majka DS; Chang RW
Rheum Dis Clin North Am; 2014 Nov; 40(4):659-68. PubMed ID: 25437283
[TBL] [Abstract][Full Text] [Related]
14. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
[TBL] [Abstract][Full Text] [Related]
15. A role for autoantibodies in atherogenesis.
Iseme RA; McEvoy M; Kelly B; Agnew L; Walker FR; Handley T; Oldmeadow C; Attia J; Boyle M
Cardiovasc Res; 2017 Aug; 113(10):1102-1112. PubMed ID: 28899001
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity.
Vuilleumier N; Montecucco F; Hartley O
World J Cardiol; 2014 May; 6(5):314-26. PubMed ID: 24944761
[TBL] [Abstract][Full Text] [Related]
17. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
Thromb Haemost; 2013 May; 109(5):854-68. PubMed ID: 23446994
[TBL] [Abstract][Full Text] [Related]
18. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Toubi E; Shoenfeld Y
Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL.
Cao P; Pan H; Xiao T; Zhou T; Guo J; Su Z
Int J Mol Sci; 2015 Jul; 16(8):17245-72. PubMed ID: 26225968
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.
Rodríguez-Carrio J; López-Mejías R; Alperi-López M; López P; Ballina-García FJ; González-Gay MÁ; Suárez A
Arthritis Rheumatol; 2016 Jun; 68(6):1367-76. PubMed ID: 26815637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
